These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 17970546)
1. [Morbid obesity, non-alcoholic fatty liver disease, metabolic syndrome and bariatric surgery]. Silvestre V; Ruano M; García-Lescún MC; Aguirregoicoa E; Criado L; Rodríguez A; Marco A; García-Blanch G Nutr Hosp; 2007; 22(5):602-6. PubMed ID: 17970546 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome. Qureshi K; Abrams GA Clin Obes; 2016 Apr; 6(2):117-23. PubMed ID: 26856683 [TBL] [Abstract][Full Text] [Related]
3. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease. Weiner RA Dig Dis; 2010; 28(1):274-9. PubMed ID: 20460923 [TBL] [Abstract][Full Text] [Related]
4. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology. Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000 [TBL] [Abstract][Full Text] [Related]
5. Long-term Results of Bariatric Surgery for Non-alcoholic Fatty Liver Disease/Non-alcoholic Steatohepatitis Treatment in Morbidly Obese Japanese Patients. Uehara D; Seki Y; Kakizaki S; Horiguchi N; Tojima H; Yamazaki Y; Sato K; Yamada M; Uraoka T; Kasama K Obes Surg; 2019 Apr; 29(4):1195-1201. PubMed ID: 30542827 [TBL] [Abstract][Full Text] [Related]
6. HSCRP as surrogate marker in predicting long term effect of bariatric surgery on resolution of non-alcoholic steatohepatitis. Tan CH; Al-Kalifah N; Lee WJ; Ser KH; Lee YC; Chen JC Asian J Surg; 2019 Jan; 42(1):203-208. PubMed ID: 29804707 [TBL] [Abstract][Full Text] [Related]
7. Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease. Liew PL; Lee WJ; Lee YC; Wang HH; Wang W; Lin YC Obes Surg; 2006 Dec; 16(12):1584-93. PubMed ID: 17217634 [TBL] [Abstract][Full Text] [Related]
8. Impact of bariatric surgery on non-alcoholic fatty liver disease. Major P; Pędziwiatr M; Rubinkiewicz M; Stanek M; Głuszewska A; Pisarska M; Małczak P; Budzyński A; Budzyński P Pol Przegl Chir; 2017 Apr; 89(2):1-4. PubMed ID: 28537562 [TBL] [Abstract][Full Text] [Related]
10. Cardiovascular benefits of bariatric surgery in morbidly obese patients. Athyros VG; Tziomalos K; Karagiannis A; Mikhailidis DP Obes Rev; 2011 Jul; 12(7):515-24. PubMed ID: 21348922 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of Non-alcoholic Fatty Liver Disease and Steatohepatitis Risk Factors in Patients Undergoing Bariatric Surgery. Morita S; Neto Dde S; Morita FH; Morita NK; Lobo SM Obes Surg; 2015 Dec; 25(12):2335-43. PubMed ID: 25920616 [TBL] [Abstract][Full Text] [Related]
12. The prevalence of nonalcoholic steatohepatitis is greater in morbidly obese men compared to women. Arun J; Clements RH; Lazenby AJ; Leeth RR; Abrams GA Obes Surg; 2006 Oct; 16(10):1351-8. PubMed ID: 17059746 [TBL] [Abstract][Full Text] [Related]
13. Effect of Body Mass Index, Metabolic Health and Adipose Tissue Inflammation on the Severity of Non-alcoholic Fatty Liver Disease in Bariatric Surgical Patients: a Prospective Study. Ooi GJ; Burton PR; Bayliss J; Raajendiran A; Earnest A; Laurie C; Kemp WW; McLean CA; Roberts SK; Watt MJ; Brown WA Obes Surg; 2019 Jan; 29(1):99-108. PubMed ID: 30229460 [TBL] [Abstract][Full Text] [Related]
14. [Nonalcoholic fatty liver disease and its association with metabolic syndrome in the preoperative period in patients undergoing bariatric surgery]. Schild BZ; Santos LN; Alves MK Rev Assoc Med Bras (1992); 2013; 59(2):155-60. PubMed ID: 23582557 [TBL] [Abstract][Full Text] [Related]
15. Percentage of excess BMI lost correlates better with improvement of metabolic syndrome after Roux-en-Y gastric bypass in morbidly obese subjects: anthropometric indexes and gastric bypass. Rossi M; Serpa Neto A; Rossi FM; Amarante RD; Alcântara GC; da Silva RB; Regina PF Surg Obes Relat Dis; 2009; 5(1):11-8. PubMed ID: 18996755 [TBL] [Abstract][Full Text] [Related]
17. The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease. Oh SY; Cho YK; Kang MS; Yoo TW; Park JH; Kim HJ; Park DI; Sohn CI; Jeon WK; Kim BI; Son BH; Shin JH Metabolism; 2006 Dec; 55(12):1604-9. PubMed ID: 17142131 [TBL] [Abstract][Full Text] [Related]
18. Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery. Verna EC; Berk PD Semin Liver Dis; 2008 Nov; 28(4):407-26. PubMed ID: 18956297 [TBL] [Abstract][Full Text] [Related]
19. Hypogonadism as an additional indication for bariatric surgery in male morbid obesity? Samavat J; Facchiano E; Lucchese M; Forti G; Mannucci E; Maggi M; Luconi M Eur J Endocrinol; 2014 Nov; 171(5):555-60. PubMed ID: 25117463 [TBL] [Abstract][Full Text] [Related]
20. Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated? Helling TS; Helzberg JH; Nachnani JS; Gurram K Surg Obes Relat Dis; 2008; 4(5):612-7. PubMed ID: 18226970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]